openPR Logo
Press release

Low Radiation Exposure Resulting in High Adoption of External Beam Radiation Therapy

12-06-2016 03:40 PM CET | Health & Medicine

Press release from: SA-BRC

Low Radiation Exposure Resulting in High Adoption of External

This report covers the market analysis for various external beam radiotherapy devices or EBRT devices such as Gamma Knife, Cyber Knife, TomoTherapy, LINACs and Proton Beam Therapy. The report also focuses on the market by application of the devices on various types of cancers such as lung cancer, prostate, breast, nead and neck, spine among others. Another chapter is dedicated to the technique and technologies that the devices are based on and provides estimates of the market by different technologies such as Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), 3-D Conformal Radiotherapy. Finally, the geographical analysis of the veterinary diagnostic imaging devices is segregated into six regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa.

The radiotherapy applications are primarily preferred in combination therapy along with chemotherapy and general surgery to enhance the quality of treatment procedures. Increasing rate of cancer incidences is driving the application market for radiotherapy. Prostate cancer, breast cancer and lung cancer represent the prime application areas of radiotherapy procedures. This is primarily due to providing novel treatment alternative for spine and neurosurgical procedures and better treatment outcome with higher protection to the healthy surrounding tissues.

Free Sample Report@ http://www.sa-brc.com/Global-External-Beam-Radiation-Therapy-Devices-Technologies-and-Applications-Market-Assessment--Forecast-2015-2019/sample9

Also termed as teletherapy, external beam therapy devices work on the principle of delivery of energy from a machine located at a distance from the patient. Some of the prime advantages of the use of such therapy are less exposure of the patient to radioactivity unlike systemic radiotherapy and brachytherapy, lesser side effects of treatment and cost effectiveness. A Linac or linear accelerator is the most important component of external beam therapy devices and perpetual variations and development in their characteristics such as electron-emitting high energy machines and proton therapy machines have rendered scope for the evolution of different types of external beam therapy. Further miniaturization of devices has led to introduction of radiosurgery systems such as Gamma Knife, TomoTherapy and CyberKnife. Radiosurgery systems though being a small contributor, they are the most technologically advanced area in the external beam therapy systems market. Synchrotron and cyclotron systems have a wide range of applications and high contribution to the field of radiation oncology. Companies such as Accuray, Elekta AB and Varian Medical systems currently dominate this market and are expected to undergo rapid growth in the next few years.

North America is the major market of external beam radiotherapy and has been driving the global market significantly. North America market is highly impacted with the reimbursement policy as it has major influence to prefer one treatment procedure to other alternatives for curtailing the treatment cost. Due to expensive treatment procedures of different cancers, physicians are only inclined to one technology which can be reimbursed majorly by the Government. Moreover, this market is fond of appraising newer technologies and supporting them with wealthy reimbursement securities. Other than the mature markets, emerging countries such as Asia and BRIC nations are the future drivers of the external radiotherapy market due to growing GDP and healthcare expenditures in these countries and their huge cancer patient base. The Asian market is expected to grow at a CAGR of 7.8% in the forecast period of 2015 to 2019.

Click For Full Report@ http://www.sa-brc.com/report/Global-External-Beam-Radiation-Therapy-Devices-Technologies-and-Applications-Market-Assessment--Forecast-2015-2019/9

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Low Radiation Exposure Resulting in High Adoption of External Beam Radiation Therapy here

News-ID: 391836 • Views:

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-2021
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2021
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Therapy

Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023. The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market. Factors that are likely to hamper the growth of the market